| Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma (NCT04191434) | EMS | 2022-07-22 |
| Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma (NCT04191447) | EMS | 2022-07-22 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma (NCT06642961) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2022-07-19 |
| Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics (NCT05448651) | Upstream Bio Inc. | 2022-07-08 |
| A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma (NCT04769869) | AstraZeneca | 2022-07-08 |
| A Study of MG-K10 in Subjects With Asthma (NCT05382910) | Shanghai Mabgeek Biotech.Co.Ltd | 2022-07-05 |
| Asthma Diagnosis Through Peak Flows (NCT05439915) | Consorci Sanitari de Terrassa | 2022-07-01 |
| Implementation of Evidence-based Breathing Retraining for Patients With Asthma in Region Zealand (NCT05531370) | Naestved Hospital | 2022-06-30 |
| Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (NCT05421598) | Sanofi | 2022-06-30 |
| Evaluation of Physical Activity in Asthmatic Subjects (NCT05486689) | Istituti Clinici Scientifici Maugeri SpA | 2022-06-30 |
| Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease (NCT05276570) | Arrowhead Pharmaceuticals | 2022-06-29 |
| Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease (NCT05292950) | Arrowhead Pharmaceuticals | 2022-06-27 |
| Nutrition for Asthmatics with Obesity (NCT05222451) | Pennington Biomedical Research Center | 2022-06-27 |
| Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma (NCT05246930) | University of Rochester | 2022-06-15 |
| A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects (NCT05332834) | SinoMab BioScience Ltd | 2022-06-14 |
| Effectiveness of a Nordic Walking in Patients With Asthma. (NCT05482620) | Universidade da Coruña | 2022-06-13 |
| First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants (NCT05366764) | Sanofi | 2022-06-08 |
| Mother-Infant Cohort Study in Malaysia and China (NCT04919265) | Universiti Putra Malaysia | 2022-06-03 |
| Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations (NCT05417906) | Changi General Hospital | 2022-06-02 |
| Avoidable Hospitalizations/ Emergency Department Visits- Systematic Review and Meta-synthesis of Qualitative Research (NCT05456906) | Kaohsiung Medical University | 2022-06-01 |
| Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma (NCT03141424) | Hvidovre University Hospital | 2022-06-01 |
| Standard Patient Training Versus Vik Chatbot Guided Training: a Randomized Controlled Trial for Asthma Patients (NCT05248126) | University Hospital, Montpellier | 2022-05-24 |
| Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma (NCT05274815) | AstraZeneca | 2022-05-17 |
| Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children (NCT05206695) | University of California, San Francisco | 2022-05-13 |
| A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions (NCT05397834) | Respirent Pharmaceuticals Co Ltd. | 2022-05-11 |
| A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® (NCT05217810) | Novartis Pharmaceuticals | 2022-05-09 |
| A 24-week rPMS Study in Real-world Setting for Enerzair (NCT05274425) | Novartis Pharmaceuticals | 2022-05-09 |
| Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (NCT05347771) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-05-04 |
| Behavioral Intervention to Increase Physical Activity in Patients with Asthma: Identifying Responders (NCT05159076) | University of Sao Paulo General Hospital | 2022-05-02 |
| Exploring the Efficacy of myAsthma in Secondary Care (NCT04744272) | my mhealth Ltd | 2022-05-01 |
| Comparison of Flutter and PEP Mask on Chest Clearance, Dyspnea in Elderly Asthmatic Patients (NCT05618873) | Riphah International University | 2022-05-01 |
| Viral Infection in Asthma (VIA) Study (NCT04380038) | University of Virginia | 2022-05-01 |
| E-cigarettes for Harm Reduction in Adults With Asthma (NCT05278065) | Brown University | 2022-05-01 |
| The Use of a Monitoring Device by General Practitioners During Out-of-hours Care (NCT05222711) | KU Leuven | 2022-05-01 |
| Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States (NCT05329194) | AstraZeneca | 2022-04-29 |
| BREATHE-Peds Pilot - I Focus Group Interviews (NCT05137223) | Columbia University | 2022-04-26 |
| Phenotyping Disease Severity in Asthma (NCT05078021) | University of Calgary | 2022-04-21 |
| Registry of Asthma Characterization and Recruitment 3 (RACR3) (NCT05272241) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-04-15 |
| BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient (NCT05322707) | Cipla Ltd. | 2022-04-15 |
| Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control (NCT05168995) | Chiesi Italia | 2022-04-12 |
| Role of Toilet Bronchoscopy in RICU (NCT04798118) | Assiut University | 2022-04-01 |
| Choice of Inhalation Device (NCT05264441) | Universitair Ziekenhuis Brussel | 2022-04-01 |
| Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma (NCT05476484) | ALK-Abelló A/S | 2022-04-01 |
| Unrefined Salmon Oil as Dietary Supplement in Adult Asthmatics (NCT05137132) | Hofseth Biocare ASA | 2022-04-01 |
| A Research Study to Explore the Impact of GP Support Via Text Messages to Patients With Asthma and/or COPD (NCT06419400) | Accurx | 2022-04-01 |
| Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases (NCT04825067) | Institute of Bioengineering and Bioimaging (IBB) | 2022-04-01 |
| Home Air Quality Impact for Adults With Asthma (NCT05224076) | University of Kansas Medical Center | 2022-03-30 |
| Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma (NCT05035862) | Emory University | 2022-03-16 |
| Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients Responding to ICS Treatment (NCT05553379) | Bosch Healthcare Solutions GmbH | 2022-03-15 |
| Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern (NCT05251402) | University of Illinois at Chicago | 2022-03-09 |
| Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China. (NCT05330637) | Shanghai Jiao Tong University School of Medicine | 2022-03-03 |
| Lignosus Rhinoceros TM02® as a Complementary Therapy for Uncontrolled Asthma (NCT06451328) | University of Malaya | 2022-03-01 |
| An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) (NCT05243680) | GlaxoSmithKline | 2022-03-01 |
| A Case-control Study on the Differentiation Between Cough Variant Asthma and Chronic Cough (NCT06199830) | The First Affiliated Hospital of Zhejiang Chinese Medical University | 2022-03-01 |
| Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers (NCT05304494) | Sanome | 2022-03-01 |
| Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol (NCT03105843) | Dr. Diane Lougheed | 2022-03-01 |
| Predictors of Non-accESs to therapeutiC EducAtion Programs Among Patients With Type 2 Diabetes, and/or Asthma, and/or Chronic Heart Failure in an Emergency Setting (NCT05320276) | Fondation Hôpital Saint-Joseph | 2022-02-28 |
| Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA (NCT05018598) | Chiesi Farmaceutici S.p.A. | 2022-02-25 |
| Study in Adult Patients With Moderate to Severe Asthma (NCT04886999) | Chiesi Farmaceutici S.p.A. | 2022-02-24 |
| COM-B Asthma Questionnaire (NCT05643924) | Portsmouth Hospitals NHS Trust | 2022-02-24 |
| Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma (NCT05036733) | University of Michigan | 2022-02-22 |
| Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (NCT05226416) | Eurasian Association of Therapists | 2022-02-21 |
| Rural Hospital-Level Care at Home for Acutely Ill Adults (NCT05256303) | Brigham and Women's Hospital | 2022-02-16 |
| Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Biological Therapy. (NCT05792592) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2022-02-15 |
| An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma (NCT05120986) | Novartis Pharmaceuticals | 2022-02-15 |
| An Online Behavior Change Intervention to Promote Physical Activity in Adults With Asthma (NCT05241223) | Universidade Norte do Paraná | 2022-02-03 |
| Study of Hospitalised Patients With Acute Respiratory Conditions (NCT05095090) | University of Leicester | 2022-02-02 |
| Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone (NCT05457855) | Brigham and Women's Hospital | 2022-02-01 |
| Primary Care Implementation and Evaluation of Coach McLungs (NCT05059210) | Wake Forest University Health Sciences | 2022-02-01 |
| Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (NCT05251259) | AstraZeneca | 2022-01-27 |
| Lung Function Outcomes Following Removal of Airway Mucus Plugs in Patients With Asthma (FOCUS) (NCT05748912) | University of California, San Francisco | 2022-01-26 |
| A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection (NCT05170243) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-01-21 |
| A Study of CM310 in Subjects With Moderate to Severe Asthma (NCT05186909) | Keymed Biosciences Co.Ltd | 2022-01-12 |
| A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS) (NCT05202262) | AstraZeneca | 2022-01-12 |
| A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects (NCT05171348) | Keymed Biosciences Co.Ltd | 2022-01-07 |
| Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database (NCT05136547) | AstraZeneca | 2022-01-06 |
| Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults (NCT04265105) | Royal College of Surgeons in Ireland - Medical University of Bahrain | 2021-12-22 |
| Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers (NCT05111262) | Washington University School of Medicine | 2021-12-16 |
| Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma (NCT05097287) | Sanofi | 2021-12-16 |
| A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists (NCT05110976) | AstraZeneca | 2021-12-16 |
| An Evaluation of 9MW1911 Injection in Healthy Subjects (NCT05803902) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2021-12-15 |
| Real-time Remote Asthma Monitoring Through Smartphone Voice Analysis (NCT05850390) | Sonde Health | 2021-12-14 |
| Clinic Versus Home Spirometry (NCT05219773) | University of Nottingham | 2021-12-14 |
| Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases (NCT04765722) | McMaster University | 2021-12-14 |
| Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma (NCT05113615) | University of Saskatchewan | 2021-12-13 |
| Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma (NCT05104892) | Sanofi | 2021-12-12 |
| Study of GSK3511294 in Healthy Chinese Participants (NCT05140200) | GlaxoSmithKline | 2021-12-10 |
| Towards Participatory Paediatric Asthma Action Plans (NCT04810169) | Assistance Publique - Hôpitaux de Paris | 2021-12-10 |
| The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients (NCT04905420) | AstraZeneca | 2021-12-08 |
| A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma (NCT05584306) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-12-06 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| Nation-wide Health Resource Consumption and Costs Associated With Mepolizumab (NCT04550780) | University Hospital, Montpellier | 2021-12-03 |
| Investigating the Effects of QVM149 on MRI Ventilation Defects (NCT04206761) | Dr. Grace Parraga | 2021-12-01 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases (NCT05147688) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-12-01 |
| Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma (NCT03825302) | Vanderbilt University Medical Center | 2021-12-01 |
| AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department (NCT04669288) | University of Arizona | 2021-11-22 |
| BREATHE: An Efficacy-implementation With Listening Sessions (NCT05045690) | Columbia University | 2021-11-19 |
| Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (NCT05084222) | Orion Corporation, Orion Pharma | 2021-11-11 |
| CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents (NCT05091034) | Columbia University | 2021-11-08 |
| Feasibility of Measuring Skin Carotenoid Level in an Asthma Clinic (NCT06636396) | University of Kansas Medical Center | 2021-11-08 |